BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33860651)

  • 1. Challenges in management of transient hyperinsulinism - a retrospective analysis of 36 severely affected children.
    Hoermann H; Roeper M; Salimi Dafsari R; Koestner F; Reinauer C; Mayatepek E; Meissner T; Kummer S
    J Pediatr Endocrinol Metab; 2021 Jul; 34(7):867-875. PubMed ID: 33860651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal Erythroblastosis May Be an Indicator of Neonatal Transient Hyperinsulinism.
    Mizumoto H; Iki Y; Yamashita S; Kawai M; Katayama T; Hata D
    Neonatology; 2015; 108(2):88-92. PubMed ID: 26044515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism.
    Malhotra N; Yau D; Cunjamalay A; Gunasekara B; S A; Gilbert C; Morgan K; Dattani M; Dastamani A
    Clin Endocrinol (Oxf); 2024 Feb; 100(2):132-137. PubMed ID: 38059644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
    Davidov AS; Elkon-Tamir E; Haham A; Shefer G; Weintrob N; Oren A; Lebenthal Y; Mandel D; Eyal O
    Eur J Pediatr; 2020 Apr; 179(4):597-602. PubMed ID: 31863303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient hyperinsulinism in an asphyxiated newborn infant with hypoglycemia.
    Clark W; O'Donovan D
    Am J Perinatol; 2001 Jun; 18(4):175-8. PubMed ID: 11444360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the duration of treatment with diazoxide in infants with prolonged hyperinsulinism (PHI).
    Raisingani M; Brar PC
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1241-1245. PubMed ID: 31465295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism.
    Hoe FM; Thornton PS; Wanner LA; Steinkrauss L; Simmons RA; Stanley CA
    J Pediatr; 2006 Feb; 148(2):207-12. PubMed ID: 16492430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism.
    Thornton PS; Alter CA; Katz LE; Baker L; Stanley CA
    J Pediatr; 1993 Oct; 123(4):637-43. PubMed ID: 8410522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinism in infants and children.
    Stanley CA
    Pediatr Clin North Am; 1997 Apr; 44(2):363-74. PubMed ID: 9130925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with diazoxide in childhood hyperinsulinism.
    Grant DB; Dunger DB; Burns EC
    Acta Endocrinol Suppl (Copenh); 1986; 279():340-5. PubMed ID: 3465173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal hyperinsulinism secondary to maternal intake of high-sugar drinks.
    West NJ; Thorpe M
    BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and management of neonatal onset hyperinsulinemic hypoglycemia: a single neonatal center experience.
    Bezirganoglu H; Okur N; Celik K; Tas FF; Ozbek MN
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2272014. PubMed ID: 37860935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Hypoglycemia Phenotype in Congenital Hyperinsulinism Due to Dominant Mutations of Uncoupling Protein 2.
    Ferrara CT; Boodhansingh KE; Paradies E; Fiermonte G; Steinkrauss LJ; Topor LS; Quintos JB; Ganguly A; De Leon DD; Palmieri F; Stanley CA
    J Clin Endocrinol Metab; 2017 Mar; 102(3):942-949. PubMed ID: 27967291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enigma of persistent hyperinsulinemic hypoglycemia of infancy.
    Daneman D; Ehrlich RM
    J Pediatr; 1993 Oct; 123(4):573-5. PubMed ID: 8410509
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.
    Kane C; Lindley KJ; Johnson PR; James RF; Milla PJ; Aynsley-Green A; Dunne MJ
    J Clin Invest; 1997 Oct; 100(7):1888-93. PubMed ID: 9312191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transient hyperinsulinism in neonates].
    Bolmasova AV; Melikyan MA; Krylova NA; Ionov OV; Ryumina II; Bockeria EL; Pekareva NA; Degtyareva AV
    Probl Endokrinol (Mosk); 2020 Sep; 66(4):61-67. PubMed ID: 33351360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent neonatal hyperinsulinemic hypoglycemia in two siblings successfully treated with diazoxide.
    Wüthrich C; Schubiger G; Zuppinger K
    Helv Paediatr Acta; 1986 Dec; 41(5):455-9. PubMed ID: 3818333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hyperinsulinism: successful conservative management.
    Horev Z; Ipp M; Levey P; Daneman D
    J Pediatr; 1991 Nov; 119(5):717-20. PubMed ID: 1941376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver injury may increase the risk of diazoxide toxicity: a case report.
    Tas E; Mahmood B; Garibaldi L; Sperling M
    Eur J Pediatr; 2015 Mar; 174(3):403-6. PubMed ID: 25618267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative use of octreotide in a newborn with persistent hyperinsulinemic hypoglycemia of infancy.
    Apak RA; Yurdakök M; Oran O; Senocak ME; Cağlar M
    J Pediatr Endocrinol Metab; 1998 Mar; 11 Suppl 1():143-5. PubMed ID: 9642652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.